COV;;;-19 vaccines can be safely given alongside influenza and other routine immunizations.
Future Research: Focus on durability of protection, variant-specific boosters, and equity in global distribution.
Risks and Trade-offs
Breakthrough Infections: Vaccinated individuals may still contract COV;;;-19, especially with immune-evading variants.
Waning Immunity: Protection decreases over time, making boosters essential.
Global Inequity: Access to updated vaccines remains uneven, leaving vulnerable populations at risk.
Conclusion:
COV;;;-19 vaccination continues to be one of the most effective public health tools.
While not perfect, vaccines drastically reduce severe outcomes and remain safe across populations.
The future lies in variant-adapted boosters, global equity, and ongoing research to refine strategies.
